ContributorsPublishersAdvertisers

Expert Ratings For Sarepta Therapeutics

Benzinga
Benzinga
 2021-10-15
Cover picture for the article

Over the past 3 months, 6 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company’s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat...

www.benzinga.com

Comments / 0

Comments / 0